Mat***tin

Head of Corporate Development

Bildung

MIT Sloan School of Management

MIT Sloan School of Management (Unknown - Present)

  • Degree: Master of Business Administration - MBA
  • Field of Study: Finance, Entrepreneurship
  • Description:

Tufts University (Unknown - Present)

  • Degree: Bachelor of Science (BS)
  • Field of Study: Chemical and Biological Engineering
  • Description:

Fähigkeiten:

MathCAD, Matlab, Aspen Plus, Stata

Berufserfahrung:

Head of Corporate Development at Syntis Bio

  • Location:
  • Duration: 2022-09 to Present
  • Description:

Partnerships & Licensing at 2 Minute Medicine

  • Location: Boston, Massachusetts, United States
  • Duration: 2020-04 to Present
  • Description:

Co-Founder, Board Director at Nucleate Bio

  • Location: Cambridge, Massachusetts, United States
  • Duration: 2019-09 to Present
  • Description:

Advisor at Old Silver VC

  • Location:
  • Duration: 2019-12 to Present
  • Description:

Associate Director, Corporate Strategy at Valo

  • Location:
  • Duration: 2020-01 to 2022-09
  • Description:
KI-Lebenslaufanalyse

Kandidaten-Intelligenzbericht

KI-gestützte Analyse aus der Perspektive eines US-Einstellungsdirektors — Bewertung von Karrierekontinuität, Wachstumstrajektorie und Rollenpassung.

Karrierekontinuität und Risikobewertung

Employment GapLow

There are no detectable gaps in employment since 2019; the candidate maintains multiple concurrent roles, indicating ongoing activity in biotech/healthcare.

Industry ConsistencyLow

Roles are concentrated in biotech, life sciences, and healthcare-related ventures (startups, partnerships, corporate strategy, and advisory), with no meaningful drift into unrelated sectors.

Tenure StabilityLow

While holding several concurrent roles, the candidate demonstrates stable engagement in core fields (Nucleate Bio since 2019, Old Silver VC since 2019, Valo until 2022, Syntis Bio since 2022, and ongoing modalities at 2 Minute Medicine). This portfolio approach is common in biotech leadership and indicates sustained involvement rather than short stints.

Education-Career MatchLow

MIT Sloan is a strong fit for senior corporate development, strategy, and licensing functions; the educational background aligns well with the candidate’s career trajectory in biotech business leadership.

Karrierewachstumskurve

Co-Founder, Board Director Entry
Nucleate Bio
2019-09 to Present
Advisor Lateral
Old Silver VC
2019-12 to Present
Associate Director, Corporate Strategy Lateral
Valo
2020-01 to 2022-09
Partnerships & Licensing Lateral
2 Minute Medicine
2020-04 to Present
Head of Corporate Development ↑ Befördert
Syntis Bio
2022-09 to Present
Bewertung:The candidate demonstrates a clear upward trajectory into senior leadership within biotech corporate development, combining startup entrepreneurship, advisory experience, and strategic/BD leadership. This profile is well-suited for C-level or VP-level roles in mid-to-growth-stage biotechs, with potential to target CBO or CSO tracks depending on fundraising and scale-up requirements.

Bestpassende Rollen (Top 5)

1

Chief Business Officer (CBO) - Biotech/ Life Sciences93% Passung

Proven leadership across corporate development, licensing, partnerships, and startup governance; strong cross-functional impact with a finance/operational mindset from MIT Sloan education.

2

Vice President / Head of Corporate Development - Biotech92% Passung

Direct alignment with current responsibilities and demonstrated deal-closure and strategic growth experience in biotech settings.

3

Chief Strategy Officer (CSO) - Biotech Startup90% Passung

Broad exposure across strategy, BD, licensing, and entrepreneur-in-residence style roles; strong founder-level perspective from Nucleate Bio.

4

VP / Director, Licensing & Partnerships - Global Pharma87% Passung

Specialized licensing/partnerships experience complements Syntis Bio and 2 Minute Medicine activities; suitable for a pharma-led business model.

5

VP, Corporate Development & Strategy - Life Sciences85% Passung

Senior BD/strategy leadership for a larger life sciences organization; leverages portfolio approach and advanced business education.

Erleben Sie AI Recruiter

Kostenlos starten. Lassen Sie Ihre Konkurrenten nicht den KI-Vorteil zuerst ergattern.

Schließen Sie sich über 10.000 Unternehmen an, die KI-gestützte Recruiting-Lösungen nutzen, um Ihren Einstellungsprozess zu automatisieren und 80% Zeitkosten zu sparen.

33% Rabatt, nur noch 48 Stunden!
Kostenlos AI testen

24/7 automatisierter Betrieb

KI-gestützte Kandidatenauswahl

Recruiting ohne geografische oder zeitliche Einschränkungen

Personalisierte intelligente Kommunikation

Automatisierte Bewertung des Kandidatenengagements

Ahmt Ihren Recruiting-Stil intelligent nach

4-monatige Geld-zurück-Garantie

Gewährleistet LinkedIn-Kontosicherheit